Trial Profile
Comparative Bioavailability Study of BIA 5-453 Under Fasted and Fed Conditions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Mar 2017
Price :
$35
*
At a glance
- Drugs Etamicastat (Primary)
- Indications Heart failure; Hypertension
- Focus Pharmacokinetics
- Sponsors Bial
- 29 Mar 2017 New trial record